Ankrd26 is a retinoic acid-responsive plasma membrane-binding and -shaping protein critical for proper cell...

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Morphogens like retinoic acid trigger cell differentiation, but downstream effectors organizing cell shape changes remain unclear.
• Aberrant plasma membrane signaling is frequently implicated in cancer development.

Purpose of the Study:

• To identify and characterize downstream effectors of morphogenic cues involved in cellular differentiation.
• To investigate the role of Ankrd26 in cell shape regulation and its connection to cancer-associated signaling pathways.

Main Methods:

• Identifying Ankrd26 as a plasma membrane-localized protein.
• Investigating Ankrd26 self-association and cluster formation.
• Analyzing the N-terminal amphipathic structure's role in membrane binding and bending.
• Utilizing gain-of-function and loss-of-function/rescue studies in neuroblastoma differentiation models.
• Examining an acute myeloid leukemia-associated Ankrd26 mutant.

Main Results:

• Ankrd26 self-associates and forms clusters at the plasma membrane in response to retinoic acid.
• An N-terminal amphipathic structure is crucial for Ankrd26's membrane binding and bending capabilities.
• An acute myeloid leukemia-associated Ankrd26 mutant lacks this structure, impairing membrane association and cell shaping.
• The Ankrd26 mutation disrupts retinoic acid/brain-derived neurotrophic factor (BDNF)-induced neuroblastoma differentiation.

Conclusions:

• Ankrd26 acts as a critical organizer of cellular differentiation platforms at the plasma membrane.
• The molecular mechanisms of Ankrd26-mediated membrane organization are elucidated.
• Impairment of Ankrd26's membrane-associated functions contributes to cancer pathomechanisms.